Log in to search using one of your social media accounts:

 

Medical News Today: Inflammatory bowel disease may raise Parkinson's risk
Having IBD is tied to a 22 percent higher risk of Parkinson's disease, according to a nationwide Danish population study that covered nearly 40 years. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 22, 2018 Category: Consumer Health News Tags: Crohn's / IBD Source Type: news

Inflammatory bowel disease may raise Parkinson's risk
Having IBD is tied to a 22 percent higher risk of Parkinson's disease, according to a nationwide Danish population study that covered nearly 40 years. (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - May 22, 2018 Category: Neurology Tags: Crohn's / IBD Source Type: news

What happens when you don’t have the right gut microbes to digest the nutrients in your food?
(Natural News) Gut bacteria aid in the proper digestion of pretty much any type of food. And the right gut bacteria are necessary for all kinds of different natural processes to occur. If they are not present, then it could lead to problems. For example, inflammatory bowel diseases (IBD) could happen, though the underlying reasons for... (Source: NaturalNews.com)
Source: NaturalNews.com - May 21, 2018 Category: Consumer Health News Source Type: news

Medical News Today: E. coli toxin linked with inflammatory bowel disease
Researchers have accidentally discovered a surprising link between microcin B17, a toxin produced by E. coli, and inflammatory bowel disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 19, 2018 Category: Consumer Health News Tags: Crohn's / IBD Source Type: news

Humira does not improve aortic vascular inflammation in psoriasis patients
(University of Pennsylvania School of Medicine) An antibody used to treat the skin disease psoriasis and other chronic autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease has no effect on aortic inflammation -- a key marker of future risk of major cardiovascular events -- unlike other antibodies that target different aspects of the immune system. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 18, 2018 Category: International Medicine & Public Health Source Type: news

Protagonist Therapeutics Appoints Bryan Giraudo to Board of Directors
NEWARK, Calif., May 16, 2018 -- (Healthcare Sales & Marketing Network) -- Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced the appointment of Bryan Giraudo to its Board of Directors. Mr. Giraudo currently serves as Chief Financial Officer of ... Biopharmaceuticals, Gastroenterology, Personnel Protagonist Therapeutics, inflammatory bowel disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news

Is Verily Making a Blood Collection Device Involving & #039;Exploding & #039; Micro-Needles?
According to a CNBC report, Verily is developing a wearable blood collection device using micro-needles and magnets in an effort to make blood collection less painful and obnoxious for patients who need to be frequently monitored. The news report cites unnamed sources who said the concept has already been tested with a watch, but the project is still years away from reaching the market. Apparently, the device would include micro-needles that would "explode" into the user's skin, then be retracted by magnets for future use. The report noted that the long-term project company faces significant scientific, technical...
Source: MDDI - May 16, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: R & D Source Type: news

Science-backed eating tips for those with inflammatory bowel disease
(Natural News) If you suffer from IBS, your diet can help treat your condition. Researchers have recently identified some science-backed eating tips for relieving or treating inflammatory bowel disease. Inflammatory bowel diseases, such as colitis and Crohn’s disease, are disorders that cause chronic inflammation in the digestive tract. The signs and symptoms that are common to... (Source: NaturalNews.com)
Source: NaturalNews.com - May 15, 2018 Category: Consumer Health News Source Type: news

Fibrosis in Ulcerative Colitis and Mucosal Inflammation Fibrosis in Ulcerative Colitis and Mucosal Inflammation
This study investigated ulcerative colitis-associated fibrosis and its possible link to clinical parameters.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 15, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Predictors of Response to Vedolizumab and Ustekinumab in IBD Predictors of Response to Vedolizumab and Ustekinumab in IBD
What factors and patient characteristics might help predict initial and long-term response to vedolizumab and ustekinumab in inflammatory bowel disease?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 8, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

InDex Pharmaceuticals Develops Oral Formulation of Cobitolimod
STOCKHOLM, May 4, 2018 -- (Healthcare Sales & Marketing Network) -- InDex Pharmaceuticals Holding AB (publ) today announced that it has developed a novel formulation of its lead drug candidate cobitolimod for oral administration, with targeted delivery to... Biopharmaceuticals, Gastroenterology InDex Pharmaceuticals, cobitolimod, ulcerative colitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 4, 2018 Category: Pharmaceuticals Source Type: news

Gilead inks $90m deal with Verily to create “molecular map” of inflammatory disease
Gilead Sciences (NSDQ:GILD) is reportedly slated to pay Alphabet’s Verily Life Sciences $90 million over three years to analyze cells from patients with rheumatoid arthritis, inflammatory bowel disease and lupus-related diseases. By probing immune cells from patients involved in Gilead’s clinical trials, the companies hope to glean a better understanding of the immunological signatures of RA, IBD and lupus-related diseases. It’s the first large-scale use of Verily’s Immunoscape platform, which combines immunogenomic phenotyping and computational analysis to profile the molecular chara...
Source: Mass Device - May 1, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Diagnostics Drug-Device Combinations Pharmaceuticals Wall Street Beat Gilead Sciences Verily Source Type: news

2 big Bay Area companies look to map, tackle inflammatory diseases
Scientific powerhouses Gilead Sciences Inc. and Verily Life Sciences will work together to find a molecular map of the immune system in lupus, rheumatoid arthritis and inflammatory bowel disease and how it responds to drugs in development. The deal, the value of which wasn't disclosed Monday, comes as the power of understanding and manipulating the immune system to tackle those conditions, cancer and other diseases has taken center stage over the past few years. Gilead (NASDAQ: GILD) will use the… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 30, 2018 Category: American Health Authors: Ron Leuty Source Type: news

2 big Bay Area companies look to map, tackle inflammatory diseases
Scientific powerhouses Gilead Sciences Inc. and Verily Life Sciences will work together to find a molecular map of the immune system in lupus, rheumatoid arthritis and inflammatory bowel disease and how it responds to drugs in development. The deal, the value of which wasn't disclosed Monday, comes as the power of understanding and manipulating the immune system to tackle those conditions, cancer and other diseases has taken center stage over the past few years. Gilead (NASDAQ: GILD) will use the… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 30, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

Gilead To Pay Verily $90 Million To Probe Immune Cells
Gilead Sciences will pay up to $90 million over three years to Verily to run a suite of tests on the white blood cells of patients with rheumatoid arthritis, inflammatory bowel disease, and lupus in the hopes of identifying which patients respond to existing drugs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 30, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NASDAQ:GILD NASDAQ:GOOG Source Type: news

Old Drug May Get New Life in Parkinson's Prevention Old Drug May Get New Life in Parkinson's Prevention
Inflammatory bowel disease raises the risk for Parkinson's disease, but anti-TNF therapy may reduce the risk, researchers report.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 25, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

IBD Associated With Increased Incidence of Parkinson's Disease
WEDNESDAY, April 25, 2018 -- Patients with inflammatory bowel disease (IBD) have increased incidence of Parkinson's disease (PD), which is attenuated with anti-tumor necrosis factor (TNF) therapy, according to a study published online April 23 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 25, 2018 Category: Pharmaceuticals Source Type: news

Health Tip: Manage Symptoms of Crohn's Disease
-- Crohn's disease is a chronic condition that causes inflammationand irritation of the digestive tract. It affects more than 500,000 people in the United States, the National Institute of Diabetes and Digestive and Kidney Diseases says. People... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 25, 2018 Category: General Medicine Source Type: news

Health Tip: Manage Symptoms of Crohn's Disease
Title: Health Tip: Manage Symptoms of Crohn's DiseaseCategory: Health NewsCreated: 4/25/2018 12:00:00 AMLast Editorial Review: 4/25/2018 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - April 25, 2018 Category: Nutrition Source Type: news

Medical News Today: What to eat and avoid on a low-fiber diet
Fiber is an essential part of a healthful diet, but some people may benefit from eating less fiber, especially if they have irritable bowel disease (IBD) or have had a recent bowel surgery. In this article, learn which foods to eat and to avoid when on a low-fiber diet, as well as tips on how to get adequate nutrients. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 20, 2018 Category: Consumer Health News Tags: Crohn's / IBD Source Type: news

Opiate Use Linked to Early Mortality in IBD Patients
WEDNESDAY, April 18, 2018 -- Heavy use of opiates among patients with inflammatory bowel diseases (IBD) is tied to increased risk of premature all-cause death, according to a study published in the April issue of Clinical Gastroenterology and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 18, 2018 Category: Pharmaceuticals Source Type: news

Vedolizumab-treated CD Patients Undergoing Abdominal Surgery Vedolizumab-treated CD Patients Undergoing Abdominal Surgery
Biologic therapies are known to increase infection risk. How does vedolizumab impact the incidence of postoperative infectious complications among Crohn's disease patients?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 17, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Long-term Efficacy, Safety of Ustekinumab in Refractory CD Long-term Efficacy, Safety of Ustekinumab in Refractory CD
This study evaluated the long-term efficacy and safety of ustekinumab in anti-TNF refractory Crohn's disease patients.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 12, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

You Asked: What Is Inflammation, And Why Should I Care About It?
Your body can heal itself, which is pretty miraculous when you sit back and think about it. If you suffer a cut or infection—or if a disease, allergen or virus finds its way into you—your immune system reacts by sending specialized white blood cells to the affected area. These white blood cells can repair damage, stop the spread of infection or illness and in some cases eradicate the intruder. This whole response is called inflammation. “Inflammation is an activation of cells and cell-derived components that have the job of fighting invasions, and in some cases just sponging up or clearing out damaged cel...
Source: TIME: Health - April 11, 2018 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized healthytime medicine Source Type: news

Sickeningly sweet: Artificial sweeteners worsen gut inflammation, intensify symptoms of Crohn's disease
(Natural News) The lure of a calorie-free sweetener is hard to beat; after all, who doesn’t want to have their cake and eat it, too? The promise of zero-calorie beverages and lower-calorie baked goods that come along with sugar substitutes are often convincing enough on their own for the calorie-conscious among us. But studies have... (Source: NaturalNews.com)
Source: NaturalNews.com - April 11, 2018 Category: Consumer Health News Source Type: news

Association of Pain Meds With IBD Flares'Inconsistent'Association of Pain Meds With IBD Flares'Inconsistent '
Contrary to generally accepted belief, there is no consistent association between acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), or COX-2 inhibitor use and the risk of inflammatory bowel disease (IBD) exacerbations, a new analysis suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 10, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Phenotype and Natural History of Elderly Onset IBD Phenotype and Natural History of Elderly Onset IBD
What are the phenotypic characteristics of elderly-onset inflammatory bowel disease? Should management differ from that of younger persons?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 10, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Autofluorescence vs Chromoendoscopy for Dysplasia Surveillance in UC Autofluorescence vs Chromoendoscopy for Dysplasia Surveillance in UC
Autofluorescence imaging is inferior to chromoendoscopy for detecting neoplasms in patients with long-standing ulcerative colitis (UC), according to results from the FIND-UC trial.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - April 9, 2018 Category: Pathology Tags: Gastroenterology News Source Type: news

Exclusive Enteral Nutrition for Pediatric Crohn's Varies Significantly Worldwide Exclusive Enteral Nutrition for Pediatric Crohn's Varies Significantly Worldwide
Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - April 6, 2018 Category: Intensive Care Tags: Pediatrics News Source Type: news

Delay J-pouch Surgery for Colitis Until Adolescence: Researchers Delay J-pouch Surgery for Colitis Until Adolescence: Researchers
In children with very-early-onset inflammatory bowel disease (VEO-IBD), J-pouch reconstruction/ileal pouch-anal anastomosis (IPAA) surgery should be delayed until adolescence, because of the possibility that the diagnosis might change over time, new research suggests.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 5, 2018 Category: Surgery Tags: Medscape Today News Source Type: news

Analysis challenges link between pain medications and inflammatory bowel disease
(Wiley) Contrary to generally accepted belief, a recent review and analysis of published studies did not reveal a consistent association between the use of nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen and exacerbation of Crohn's disease and ulcerative colitis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 5, 2018 Category: International Medicine & Public Health Source Type: news

Advice lacking on pregnancy for patients with bowel condition
A study chronicling the experiences of women with inflammatory bowel disease (IBD) during and after pregnancy found nurses and midwives were often unable to provide information and advice. (Source: Nursing Times)
Source: Nursing Times - April 3, 2018 Category: Nursing Source Type: news

Major new study links IBD to increased heart attack risk
(Natural News) A study that involved 22 million participants suggests that there is a link between inflammatory bowel disease (IBD) and the risk of heart disease and heart attacks. The study was carried out by a team of researchers from the University Hospitals Harrington Heart & Vascular Institute who examined the potential role IBD may have... (Source: NaturalNews.com)
Source: NaturalNews.com - April 2, 2018 Category: Consumer Health News Source Type: news

Better Outcomes After End-to-End Ileocecal Anastomosis in Crohn's Better Outcomes After End-to-End Ileocecal Anastomosis in Crohn's
Following intestinal resection in Crohn's disease, end-to-end ileocecal anastomosis (ETEA) is associated with better outcomes than is side-to-side anastomosis (STSA), according to a registry study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 2, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Make the Diagnosis: A Painful, Deep Pustule: Part of a Bigger Problem?
(MedPage Today) -- Case Findings: A 55-year-old man with a history of inflammatory bowel disease reported a very painful, deep-seated pustule on his leg that looked like it might eventually rupture. He also had a fever and some arthralgia, but he wasn't sure if they were related. Can you diagnose the patient? (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 29, 2018 Category: Dermatology Source Type: news

Colon signaling pathway key to inflammatory bowel disease
(Tokyo Medical and Dental University) Inflammatory bowel disease (IBD) develops because of an uncontrolled immune response in the colon. Japanese research led by Tokyo Medical and Dental University (TMDU) showed that a signaling pathway underlies the differentiation of white blood cells into a population capable of inducing inflammation. This signaling pathway also enhanced the expression of genes encoding inflammatory mediators, opening up the possibility of developing drugs to target these mechanisms in IBD therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 29, 2018 Category: International Medicine & Public Health Source Type: news

Magician Dynamo opens up about Crohn's struggle
Images posted to social media by the magician have prompted others to share their stories of Crohn's disease. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 27, 2018 Category: Consumer Health News Source Type: news

Dynamo Crohn's selfie prompts others to share
Images posted to social media by the magician have prompted others to share their stories of Crohn's disease. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 27, 2018 Category: Consumer Health News Source Type: news

Tofacitinib and Biological Therapies for Ulcerative Colitis Tofacitinib and Biological Therapies for Ulcerative Colitis
Tofacitinib is currently under review as induction and/or maintenance therapy for adult patients with moderate-to-severe ulcerative colitis. How does it compare with other biologics?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 27, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Could This Device Replace Drugs for Rheumatoid Arthritis Treatment?
SetPoint Medical has launched a pilot trial to assess the safety and efficacy of a bioelectronics device in patients, who are suffering from rheumatoid arthritis and who are not adequately responsive to multiple biologic agents. The study will enroll a total of 15 subjects, aged 22 to 75, across seven U.S. investigational centers. Valencia, CA-based SetPoint's approach toward treating RA is designed to supplement the body's natural inflammatory reflex by providing "built-in" therapy and is intended to improve safety compared with drugs or biologic solutions. Currently pharmaceutical options are used to treat...
Source: MDDI - March 26, 2018 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Implants Source Type: news

Fecal Microbiota Profile Predicts Ustekinumab Response in Crohn's Fecal Microbiota Profile Predicts Ustekinumab Response in Crohn's
Data on patients ’ fecal microbiota can be used to predict their response to ustekinumab therapy for Crohn's disease, researchers report.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 26, 2018 Category: Pathology Tags: Gastroenterology News Source Type: news

EMA Committee Backs Remicade Biosimilar Zessly EMA Committee Backs Remicade Biosimilar Zessly
The committee favors marketing the infliximab biosimilar product Zessly for treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and psoriasis.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 23, 2018 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

DPP-4 Inhibitors May Increase Risk for IBD in Diabetes Patients DPP-4 Inhibitors May Increase Risk for IBD in Diabetes Patients
The oral, incretin-based hypoglycemic agent was associated with a 75% increased risk for inflammatory bowel disease in adults with type 2 diabetes in a population-based study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 22, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Class of diabetes drugs may be linked to increased risk of IBD
Diabetes patients taking dipeptidyl peptidase-4 inhibitors (DPP-4), commonly known as gliptins, may have an increased risk of also developing inflammatory bowel disease, warn Canadian researchers. (Source: Nursing Times)
Source: Nursing Times - March 22, 2018 Category: Nursing Source Type: news

Switching From Infliximab to Biosimilar in Patients With IBD Switching From Infliximab to Biosimilar in Patients With IBD
Two infliximab biosimilars are currently available for the treatment of inflammatory bowel disease, at a much lower cost than infliximab innovator. Can patients be safely switched?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 20, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Inflammatory Bowel Disease an Independent Risk Factor for MI Inflammatory Bowel Disease an Independent Risk Factor for MI
Adults with IBD need close monitoring and aggressive screening for cardiovascular risk factors, researchers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 19, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Higher dose of Arena Pharma's bowel disease drug meets study goal
(Reuters) - Arena Pharmaceuticals Inc said on Monday a higher dose of its experimental drug succeeded in improving symptoms associated with ulcerative colitis, a chronic bowel disease, in a mid-stage study. (Source: Reuters: Health)
Source: Reuters: Health - March 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Ask What Not to Eat When You Have Crohns Disease
What Not to Eat When You Have Crohn ’s Disease (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - March 19, 2018 Category: General Medicine Source Type: news

Splenda may intensify Crohn's symptoms, study finds
Splenda, an artificial sweetener, could intensify the symptoms of Crohn's disease in people who have it, according to a study with mice. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 16, 2018 Category: Consumer Health News Source Type: news

Artificial sweetener Splenda could intensify symptoms in those with Crohn's disease
(Case Western Reserve University) In a study that has implications for humans with inflammatory diseases, researchers have found that, given over a six-week period, the artificial sweetener sucralose, known by the brand name Splenda, worsens gut inflammation in mice with Crohn's disease, but had no substantive effect on those without the condition. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 15, 2018 Category: International Medicine & Public Health Source Type: news